New CKM Guideline Reframes Weight as Key Health Risk

The first-ever clinical guideline for cardiovascular-kidney-metabolic syndrome (CKM syndrome), jointly issued by the American Heart Association and the American College of Cardiology, identifies obesity as a key driver of this interconnected health crisis. Published today, the guideline aims to raise awareness about how heart disease, kidney disease, and metabolic conditions like diabetes and obesity are linked. With nearly 9 in 10 U.S. adults having at least one component of CKM syndrome—including high blood pressure, abnormal cholesterol, high blood glucose, reduced kidney function, or excess weight—the new recommendations emphasize prevention-focused conversations about weight management. Dr. Chiadi E. Ndumele, chair of the writing committee, stresses that weight is not just a number on a scale; rather, it's about how fat tissue affects metabolic health, including blood sugar regulation and fat storage. The guideline replaces the 2013 obesity management guideline and provides a framework for clinicians to discuss weight non-judgmentally, framed as a risk factor for organ damage rather than a cosmetic issue.

The guideline highlights the importance of early intervention to stop or reverse the progression of CKM syndrome, which can lead to diabetes, kidney disease, heart failure, and stroke. Dr. Ambar Kulshreshtha, a primary care physician and co-author, notes that prevention is as important as treatment. The condition progresses when abdominal fat causes inflammation, leading to insulin resistance and vascular problems. The guideline includes proven strategies like healthy lifestyle practices and effective medications such as SGLT2 inhibitors, GLP-1 based therapies, and nonsteroidal mineralocorticoid receptor antagonists, which benefit multiple body systems. Coordinated care using CKM navigators is recommended to bridge gaps between primary care and specialists, ensuring patients receive holistic treatment. Dr. Fatima Rodriguez, vice-chair of the writing committee, emphasizes that patients appreciate being seen as a whole person, with the patient as team captain.

The American Heart Association launched the CKM Health Initiative in 2024 to improve diagnosis and treatment. The guideline also addresses social barriers to healthy lifestyle and quality healthcare, providing social support as needed. With obesity rates rising, this guideline reframes weight as a critical health risk, urging clinicians to initiate early conversations. As Dr. Ndumele states, the goal is to shift paradigms and help individuals prevent disease long-term. The full guideline is available in Circulation and includes resources for patients and professionals, such as how weight impacts health and assessing weight for CKM risk. By integrating care across specialties, this guideline aims to reduce the burden of CKM syndrome, a growing public health threat affecting millions.